Point-of-Care Diagnostic Detection System
Maven Products
MAVEN Lateral Flow Analysis (LFA) diagnostic solutions (assay cartridges & analyzers) identifying and quantifying infectious diseases
- Schistosoma
- Leprosy
- Tuberculosis
- IL6 (Cytokine responsible for inflamation)
- SARS-CoV-2 antigen (in development)
MAVEN’s technology provides the following differentiated performance:
- High sensitivity often down to 1 picogram / ml (100x lower LOD over gold-based assays)
- Unambiguous results by leveraging machine detection and machine learning
- Unaffected by interferences and backbround due to unique range of wavelengths used for excitation and detectio
- Quantification of viral, cytokine or antibody level and ratio of multiplexed targets enabling medical professionals to follow disease progression and evaluate the effect of therapeutics
MAVEN’s core nanocrystal reporter technology is also useful in ELISA and other lab-based diagnostic systems
MAVEN leverage world-class analyzer technology produced by QIAGEN, a leading global supplier in diagnostic equipment. MAVEN brings its proprietary optical engine and detection methods to provide enhanced performance matched to our reporter materials and lateral flow assay designs.
Small, portable size: 9.3 × 8.5 × 4.1 in. (L × W × H); 5.5 lbs.
Small, standalone desktop instrument
User interface: Interactive 17.8 cm (7 in.) touchscreen
Connections: 4 + 1 × USB, Ethernet, plus optional WLAN and Bluetooth
Measurement time:<30 seconds (for one wavelength channel)
Full standalone operation or networked
Data entry via touchscreen, bar code scanner, radio-frequency identification (RFID) reader
User access control, full traceability of results,LIS and HIS connectivity (HL7 interface plus optional POCT-1A)